trial

The Effectiveness of the Meta-cognitive Training Among Patients With Chronic Schizophrenia

NCTId NCT02187692
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 50 (actual)
Sponsored by Medical University of Warsaw
Primary completion 2013-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
50 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2012-08
Primary completion
2013-04
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
MCT

Sponsors

Medical University of WarsawLead Sponsor

Investigators

1
Łukasz Gawęda, ProfessorPrincipal Investigator

Sites

1 total
Warsaw, Poland

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2013-04
Status
COMPLETED
relationships
The graph out of here
drug
MCT
drug
lead_sponsor
Medical University of Warsaw
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Łukasz Gawęda, Professor
person